Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1068 | 1069 | 1083 | 1197 | 1527 | 2695 |
Fund Return | 6.83% | 6.93% | 8.3% | 6.17% | 8.83% | 10.42% |
Place in category | 909 | 366 | 1457 | 546 | 368 | 100 |
% in Category | 50 | 19 | 87 | 42 | 33 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CI Black Creek Global Leaders D | 4.52B | 6.58 | 5.42 | 9.66 | ||
CI Signature Select Canadian Class | 2.75B | 7.34 | 7.32 | 8.55 | ||
CI Cambridge Canadian Dividend F | 1.7B | 3.16 | 6.82 | 9.32 | ||
CI Cambridge Canadian Div E CAD | 1.7B | 2.83 | 5.82 | 8.25 | ||
CI Cambridge Canadian Dividend D | 1.7B | 2.92 | 6.08 | 8.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer Global Equity | 12.88B | 3.94 | 7.52 | 10.88 | ||
Capital Group Glbal Equity Fd F CAD | 13B | 11.34 | 2.77 | 11.11 | ||
Capital Group Glbal Equity Fd A CAD | 13B | 10.93 | 1.65 | 9.88 | ||
Capital Group Glbal Equity Fd D CAD | 13B | 11.21 | 2.42 | 10.61 | ||
Fidelity Global Innovators Class F | 12.38B | 23.15 | 9.70 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Weir Group | GB0009465807 | 4.84 | 2,124.00 | -1.12% | |
DBS | SG1L01001701 | 4.58 | 35.99 | +1.04% | |
Zebra | US9892071054 | 4.47 | 312.34 | -1.35% | |
Bureau Veritas | FR0006174348 | 4.41 | 27.60 | -0.58% | |
Kuehne & Nagel | CH0025238863 | 4.24 | 255.50 | +1.71% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review